Literature DB >> 8288561

Stabilization of the EBNA1 protein on the Epstein-Barr virus latent origin of DNA replication by a DNA looping mechanism.

L Frappier1, K Goldsmith, L Bendell.   

Abstract

DNA replication from the Epstein-Barr virus latent origin of replication, oriP, is activated by Epstein-Barr nuclear antigen 1 (EBNA1). This activation involves the binding of EBNA1 dimers to multiple sites present in the two noncontiguous functional elements of oriP, the dyad symmetry element (DS) from which replication initiates, and the family of repeats (FR) enhancer element. EBNA1 complexes formed on the FR and DS elements of oriP interact by a DNA looping mechanism. This interaction requires EBNA1 sequences in addition to those required for DNA binding and dimerization. To map the EBNA1 sequences required for the efficient interaction of FR- and DS-bound EBNA1 complexes, we have overproduced in Escherichia coli and purified a series of EBNA1 N-terminal truncation mutants, all of which retain the DNA binding and dimerization domains. The results of electron microscopy and ligation-enhancement assays using these mutants indicated that EBNA1 sequences between amino acids 350 and 361 are required for the efficient interaction of FR- and DS-bound EBNA1 complexes. EBNA1-mediated FR-DS interactions were shown to stabilize EBNA1 binding to the DS element, while EBNA1-mediated DS-DS interactions did not. These results suggest that the stabilization of EBNA1 on the DS element, which occurs as a result of EBNA1-mediate oriP looping, may be important for the activation of DNA replication from the DS element.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8288561

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  The linking regions of EBNA1 are essential for its support of replication and transcription.

Authors:  D Mackey; B Sugden
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Epstein-Barr nuclear antigen 1 binds and destabilizes nucleosomes at the viral origin of latent DNA replication.

Authors:  T M Avolio-Hunter; P N Lewis; L Frappier
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

3.  Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1.

Authors:  Hong Wu; Priya Kapoor; Lori Frappier
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.

Authors:  E R Leight; B Sugden; E R Light
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  Multiple homeostatic mechanisms in the control of P1 plasmid replication.

Authors:  Nilangshu Das; Majda Valjavec-Gratian; Ashish N Basuray; Richard A Fekete; Peter P Papp; Johan Paulsson; Dhruba K Chattoraj
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-11       Impact factor: 11.205

6.  Dependence of transcriptional repression on CpG methylation density.

Authors:  C L Hsieh
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

7.  Looping dynamics of linear DNA molecules and the effect of DNA curvature: a study by Brownian dynamics simulation.

Authors:  H Merlitz; K Rippe; K V Klenin; J Langowski
Journal:  Biophys J       Date:  1998-02       Impact factor: 4.033

8.  Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.

Authors:  Julianna S Deakyne; Kimberly A Malecka; Troy E Messick; Paul M Lieberman
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

9.  Spo0A, the key transcriptional regulator for entrance into sporulation, is an inhibitor of DNA replication.

Authors:  Virginia Castilla-Llorente; Daniel Muñoz-Espín; Laurentino Villar; Margarita Salas; Wilfried J J Meijer
Journal:  EMBO J       Date:  2006-08-03       Impact factor: 11.598

10.  Epstein-Barr virus replication studies and their application to vector design.

Authors:  P M Brickell; M S Patel
Journal:  Mol Biotechnol       Date:  1995-06       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.